Best of IGCS 2022 Annual Global Meeting-Master Session: Vulvar Cancer

Video Transcription
Video Summary
The video was a recording of a Vulvar Cancer Master Session entitled Modern Management. The session was chaired by Dr. Lillian Jian from the Sunnybrook Odette Cancer Center, Dr. David Gaffney from the University of Utah, and Dr. Micah Oonk from the University Medical Center Groningen. The session consisted of several presentations on various topics related to the management of vulvar cancer. <br /><br />Dr. Flora Hinton presented on the new FIGO 2021 staging for vulvar cancer, discussing the changes and implications for management. She explained that the staging system has been simplified and now includes eight subdivisions instead of 11. The depth of invasion measurement has also changed, and lymph node metastases have been subdivided into macro and micrometastases and isolated tumor cells. The presentation highlighted the downstaging of advanced stage tumors and the impact on prognosis. The alternative method of measuring depth of invasion was also discussed, but further prospective studies are needed to validate its effectiveness. The presentation concluded that lymph node involvement remains the most important prognostic factor.<br /><br />Dr. Mario Letaio presented on the use of indocyanine green for central nodes in vulvar cancer and provided practical tips for surgeons. He discussed the previous standard method of using technetium-99 in combination with blue dye for sentinel lymph node mapping, and the challenges and limitations of this approach. He then introduced the use of indocyanine green as an alternative method and demonstrated its benefits, including real-time imaging and potentially lower costs. He emphasized that further research and prospective studies are needed to determine the optimal use of indocyanine green in vulvar cancer.<br /><br />Dr. Alexandra Taylor discussed aspects of adjuvant management in vulvar melanoma. She highlighted the lack of data specific to vulvar melanoma and the challenges in managing this rare tumor type. She discussed the importance of achieving negative margins in surgical resection and the role of sentinel lymph node assessment in determining lymph node involvement. Adjuvant radiotherapy was also discussed, with evidence showing improved local control but no significant impact on overall survival. The presentation concluded with a discussion on the potential of immunotherapy in vulvar melanoma and the need for trials specifically tailored to this patient population.<br /><br />The video provided valuable information on the current management of vulvar cancer and vulvar melanoma, highlighting the challenges and advancements in the field.
Keywords
Vulvar Cancer Master Session
Modern Management
Dr. Lillian Jian
Dr. David Gaffney
Dr. Micah Oonk
FIGO 2021 staging
indocyanine green
adjuvant management
vulvar melanoma